For its fourth fiscal quarter (ending December 31), AptarGroup Inc. (NYSE: ATR) has reported a 60% increase in E.P.S. from $0.95 a year ago to $1.52 in the current quarter. For the latest four quarters […]
AMCON Distributing Co (NYSEAMERICAN: DIT) stock closed at $149.10 on 2/6/25 after a major increase of 15.7%. Moreover, this advance was accompanied by exceptionally high trading volume at 1036% of normal. The stock has risen […]
MDU Resources Group Inc. (NYSE: MDU) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.35 versus $0.84 for the same period a year ago — a decline of -58%. For the […]
Huntington Ingalls Industries In (NYSE: HII) has reported E.P.S. of $3.15 for its fourth fiscal quarter (ending December 31) versus $6.90 for the same period a year ago — a decline of -54%. For the […]
On 2/6/25, Hologic Inc (NASDAQ: HOLX) stock suffered a major decline of -10.1%, closing at $65.45. Moreover, trading volume in this decline was exceptionally high at 327% of normal. The stock has performed in line […]
Haemonetics Corp (NYSE: HAE) has reported earnings for its third fiscal quarter (ending December 31) of $0.75 versus $0.62 for the same period a year ago — an increase of 21%. For the latest four […]
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock suffered a major decline of -15.1% on 2/6/25. The shares closed at $6.62. Moreover, trading volume in this decline was unusually high at 197% of normal. The stock has […]
For its fourth fiscal quarter (ending December 31), Zimmer Biomet Holdings Inc (NYSE: ZBH) has reported a -41% decline in E.P.S. from $2.02 a year ago to $1.20 in the current quarter. For the latest […]
Terex Corp (NYSE: TEX) has reported E.P.S. of $-0.03 for its fourth fiscal quarter (ending December 31) versus $1.90 for the same period a year ago — a decline of -102%. E.P.S. were $5.00 for […]
Synaptics Inc (NASDAQ: SYNA) has reported E.P.S. of $0.05 for its second fiscal quarter (ending December 31) versus $-0.23 for the same period a year ago — a decline of -122%. For the latest four […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research